RoVI Study

• Research type

  Research Study

• Full title

  RoVI: Impact of maternally derived antibodies and infant microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants.

• IRAS ID

  194486

• Contact name

  Miren Iturriza-Gomara

• Contact email

  miren@liverpool.ac.uk

• Duration of Study in the UK

  2 years, 6 months, 13 days

• Research summary

  This project will investigate key maternal and infant factors that may reduce rotavirus (RV) vaccine performance in infants living in low income countries. Rotavirus is the leading cause of severe gastroenteritis in infants worldwide.

• REC name

  North West - Liverpool Central Research Ethics Committee

• REC reference

  15/NW/0924

• Date of REC Opinion

  22 Dec 2015

• REC opinion

  Favourable Opinion